Skip to main content
PMC home page
The EMBO Journal logoLink to The EMBO Journal
. 1999 Jan 4;18(1):9–21. doi: 10.1093/emboj/18.1.9

Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors.

A C Papageorgiou 1, C M Collins 1, D M Gutman 1, J B Kline 1, S M O'Brien 1, H S Tranter 1, K R Acharya 1
PMCID: PMC1171097  PMID: 9878045

Abstract

Streptococcal pyrogenic exotoxin A (SpeA) is a superantigen produced by Streptococcus pyogenes and is associated with severe infections characterized by rash, hypotension, multiorgan failure and a high mortality rate. In this study, an allelic form of this toxin, SpeA1, was crystallized with four molecules in the crystallographic asymmetric unit and its crystal structure was determined at 2.6 A resolution. The crystallographic R-factor was 19.4% (33 497 reflections) for 7031 protein atoms and 88 water molecules. The overall structure of SpeA1 is considerably similar to that of other prototype microbial superantigens, either of staphylococcal or streptococcal origin, but has greatest similarity to staphylococcal enterotoxin C (SEC). Based on structural and mutagenesis data, we have mapped several important residues on the toxin molecule, which are involved in the recognition of major histocompatibility complex (MHC) class II molecules and T-cell receptors. Also, the toxin appears to possess a potential zinc-binding site which may have implications in binding to particular MHC class II molecules. Finally, we propose models for SpeA1-MHC class II and SpeA1-T-cell receptor association and the relevance of this phenomenon to the superantigenic action of this toxin is considered.

Full Text

The Full Text of this article is available as a PDF (914.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe J., Forrester J., Nakahara T., Lafferty J. A., Kotzin B. L., Leung D. Y. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol. 1991 Jun 1;146(11):3747–3750. [PubMed] [Google Scholar]
  2. Acharya K. R., Passalacqua E. F., Jones E. Y., Harlos K., Stuart D. I., Brehm R. D., Tranter H. S. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature. 1994 Jan 6;367(6458):94–97. doi: 10.1038/367094a0. [DOI] [PubMed] [Google Scholar]
  3. Barton G. J. ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng. 1993 Jan;6(1):37–40. doi: 10.1093/protein/6.1.37. [DOI] [PubMed] [Google Scholar]
  4. Bohach G. A., Fast D. J., Nelson R. D., Schlievert P. M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol. 1990;17(4):251–272. doi: 10.3109/10408419009105728. [DOI] [PubMed] [Google Scholar]
  5. Braun M. A., Gerlach D., Hartwig U. F., Ozegowski J. H., Romagné F., Carrel S., Köhler W., Fleischer B. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins). J Immunol. 1993 Mar 15;150(6):2457–2466. [PubMed] [Google Scholar]
  6. Davis M. M., Boniface J. J., Reich Z., Lyons D., Hampl J., Arden B., Chien Y. Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol. 1998;16:523–544. doi: 10.1146/annurev.immunol.16.1.523. [DOI] [PubMed] [Google Scholar]
  7. Esnouf R. M. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J Mol Graph Model. 1997 Apr;15(2):132-4, 112-3. doi: 10.1016/S1093-3263(97)00021-1. [DOI] [PubMed] [Google Scholar]
  8. Fields B. A., Malchiodi E. L., Li H., Ysern X., Stauffacher C. V., Schlievert P. M., Karjalainen K., Mariuzza R. A. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature. 1996 Nov 14;384(6605):188–192. doi: 10.1038/384188a0. [DOI] [PubMed] [Google Scholar]
  9. Garcia K. C., Degano M., Stanfield R. L., Brunmark A., Jackson M. R., Peterson P. A., Teyton L., Wilson I. A. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science. 1996 Oct 11;274(5285):209–219. doi: 10.1126/science.274.5285.209. [DOI] [PubMed] [Google Scholar]
  10. Hartwig U. F., Fleischer B. Mutations affecting MHC class II binding of the superantigen streptococcal erythrogenic toxin A. Int Immunol. 1993 Aug;5(8):869–875. doi: 10.1093/intimm/5.8.869. [DOI] [PubMed] [Google Scholar]
  11. Hartwig U. F., Gerlach D., Fleischer B. Major histocompatibility complex class II binding site for streptococcal pyrogenic (erythrogenic) toxin A. Med Microbiol Immunol. 1994 Nov;183(5):257–264. doi: 10.1007/BF00198459. [DOI] [PubMed] [Google Scholar]
  12. Hauser A. R., Stevens D. L., Kaplan E. L., Schlievert P. M. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol. 1991 Aug;29(8):1562–1567. doi: 10.1128/jcm.29.8.1562-1567.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Herman A., Kappler J. W., Marrack P., Pullen A. M. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol. 1991;9:745–772. doi: 10.1146/annurev.iy.09.040191.003525. [DOI] [PubMed] [Google Scholar]
  14. Hoffmann M. L., Jablonski L. M., Crum K. K., Hackett S. P., Chi Y. I., Stauffacher C. V., Stevens D. L., Bohach G. A. Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect Immun. 1994 Aug;62(8):3396–3407. doi: 10.1128/iai.62.8.3396-3407.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hoge C. W., Schwartz B., Talkington D. F., Breiman R. F., MacNeill E. M., Englender S. J. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA. 1993 Jan 20;269(3):384–389. [PubMed] [Google Scholar]
  16. Jardetzky T. S., Brown J. H., Gorga J. C., Stern L. J., Urban R. G., Chi Y. I., Stauffacher C., Strominger J. L., Wiley D. C. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994 Apr 21;368(6473):711–718. doi: 10.1038/368711a0. [DOI] [PubMed] [Google Scholar]
  17. Jones T. A., Zou J. Y., Cowan S. W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991 Mar 1;47(Pt 2):110–119. doi: 10.1107/s0108767390010224. [DOI] [PubMed] [Google Scholar]
  18. Kabsch W., Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983 Dec;22(12):2577–2637. doi: 10.1002/bip.360221211. [DOI] [PubMed] [Google Scholar]
  19. Karp D. R., Long E. O. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E. J Exp Med. 1992 Feb 1;175(2):415–424. doi: 10.1084/jem.175.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kim J., Urban R. G., Strominger J. L., Wiley D. C. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science. 1994 Dec 16;266(5192):1870–1874. doi: 10.1126/science.7997880. [DOI] [PubMed] [Google Scholar]
  21. Kline J. B., Collins C. M. Analysis of the interaction between the bacterial superantigen streptococcal pyrogenic exotoxin A (SpeA) and the human T-cell receptor. Mol Microbiol. 1997 Apr;24(1):191–202. doi: 10.1046/j.1365-2958.1997.3381696.x. [DOI] [PubMed] [Google Scholar]
  22. Kline J. B., Collins C. M. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect Immun. 1996 Mar;64(3):861–869. doi: 10.1128/iai.64.3.861-869.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kotb M. Superantigens of gram-positive bacteria: structure-function analyses and their implications for biological activity. Curr Opin Microbiol. 1998 Feb;1(1):56–65. doi: 10.1016/s1369-5274(98)80143-4. [DOI] [PubMed] [Google Scholar]
  24. Leder L., Llera A., Lavoie P. M., Lebedeva M. I., Li H., Sékaly R. P., Bohach G. A., Gahr P. J., Schlievert P. M., Karjalainen K. A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J Exp Med. 1998 Mar 16;187(6):823–833. doi: 10.1084/jem.187.6.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Leonard B. A., Lee P. K., Jenkins M. K., Schlievert P. M. Cell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity. Infect Immun. 1991 Mar;59(3):1210–1214. doi: 10.1128/iai.59.3.1210-1214.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Li H., Llera A., Mariuzza R. A. Structure-function studies of T-cell receptor-superantigen interactions. Immunol Rev. 1998 Jun;163:177–186. doi: 10.1111/j.1600-065x.1998.tb01196.x. [DOI] [PubMed] [Google Scholar]
  27. Li P. L., Tiedemann R. E., Moffat S. L., Fraser J. D. The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action. J Exp Med. 1997 Aug 4;186(3):375–383. doi: 10.1084/jem.186.3.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Malchiodi E. L., Eisenstein E., Fields B. A., Ohlendorf D. H., Schlievert P. M., Karjalainen K., Mariuzza R. A. Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med. 1995 Dec 1;182(6):1833–1845. doi: 10.1084/jem.182.6.1833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 May 11;248(4956):705–711. doi: 10.1126/science.2185544. [DOI] [PubMed] [Google Scholar]
  30. Merritt E. A., Murphy M. E. Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr. 1994 Nov 1;50(Pt 6):869–873. doi: 10.1107/S0907444994006396. [DOI] [PubMed] [Google Scholar]
  31. Murzin A. G., Brenner S. E., Hubbard T., Chothia C. SCOP: a structural classification of proteins database for the investigation of sequences and structures. J Mol Biol. 1995 Apr 7;247(4):536–540. doi: 10.1006/jmbi.1995.0159. [DOI] [PubMed] [Google Scholar]
  32. Musser J. M., Hauser A. R., Kim M. H., Schlievert P. M., Nelson K., Selander R. K. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2668–2672. doi: 10.1073/pnas.88.7.2668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Musser J. M., Nelson K., Selander R. K., Gerlach D., Huang J. C., Kapur V., Kanjilal S. Temporal variation in bacterial disease frequency: molecular population genetic analysis of scarlet fever epidemics in Ottawa and in eastern Germany. J Infect Dis. 1993 Mar;167(3):759–762. doi: 10.1093/infdis/167.3.759. [DOI] [PubMed] [Google Scholar]
  34. Nelson K., Schlievert P. M., Selander R. K., Musser J. M. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J Exp Med. 1991 Nov 1;174(5):1271–1274. doi: 10.1084/jem.174.5.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Papageorgiou A. C., Acharya K. R., Shapiro R., Passalacqua E. F., Brehm R. D., Tranter H. S. Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure. 1995 Aug 15;3(8):769–779. doi: 10.1016/s0969-2126(01)00212-x. [DOI] [PubMed] [Google Scholar]
  36. Papageorgiou A. C., Acharya K. R. Superantigens as immunomodulators: recent structural insights. Structure. 1997 Aug 15;5(8):991–996. doi: 10.1016/s0969-2126(97)00252-9. [DOI] [PubMed] [Google Scholar]
  37. Papageorgiou A. C., Brehm R. D., Leonidas D. D., Tranter H. S., Acharya K. R. The refined crystal structure of toxic shock syndrome toxin-1 at 2.07 A resolution. J Mol Biol. 1996 Jul 26;260(4):553–569. doi: 10.1006/jmbi.1996.0421. [DOI] [PubMed] [Google Scholar]
  38. Papageorgiou A. C., Tranter H. S., Acharya K. R. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J Mol Biol. 1998 Mar 20;277(1):61–79. doi: 10.1006/jmbi.1997.1577. [DOI] [PubMed] [Google Scholar]
  39. Prasad G. S., Earhart C. A., Murray D. L., Novick R. P., Schlievert P. M., Ohlendorf D. H. Structure of toxic shock syndrome toxin 1. Biochemistry. 1993 Dec 21;32(50):13761–13766. doi: 10.1021/bi00213a001. [DOI] [PubMed] [Google Scholar]
  40. Proft T., Fraser J. Superantigens: just like peptides only different. J Exp Med. 1998 Mar 16;187(6):819–821. doi: 10.1084/jem.187.6.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Roggiani M., Stoehr J. A., Leonard B. A., Schlievert P. M. Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants. Infect Immun. 1997 Jul;65(7):2868–2875. doi: 10.1128/iai.65.7.2868-2875.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Roussel A., Anderson B. F., Baker H. M., Fraser J. D., Baker E. N. Crystal structure of the streptococcal superantigen SPE-C: dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules. Nat Struct Biol. 1997 Aug;4(8):635–643. doi: 10.1038/nsb0897-635. [DOI] [PubMed] [Google Scholar]
  43. Schad E. M., Papageorgiou A. C., Svensson L. A., Acharya K. R. A structural and functional comparison of staphylococcal enterotoxins A and C2 reveals remarkable similarity and dissimilarity. J Mol Biol. 1997 Jun 6;269(2):270–280. doi: 10.1006/jmbi.1997.1023. [DOI] [PubMed] [Google Scholar]
  44. Schad E. M., Zaitseva I., Zaitsev V. N., Dohlsten M., Kalland T., Schlievert P. M., Ohlendorf D. H., Svensson L. A. Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J. 1995 Jul 17;14(14):3292–3301. doi: 10.1002/j.1460-2075.1995.tb07336.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Stevens D. L. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis. 1995 Jul-Sep;1(3):69–78. doi: 10.3201/eid0103.950301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Stuart D. I., Levine M., Muirhead H., Stammers D. K. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. J Mol Biol. 1979 Oct 15;134(1):109–142. doi: 10.1016/0022-2836(79)90416-9. [DOI] [PubMed] [Google Scholar]
  47. Sundström M., Abrahmsén L., Antonsson P., Mehindate K., Mourad W., Dohlsten M. The crystal structure of staphylococcal enterotoxin type D reveals Zn2+-mediated homodimerization. EMBO J. 1996 Dec 16;15(24):6832–6840. [PMC free article] [PubMed] [Google Scholar]
  48. Swaminathan S., Furey W., Pletcher J., Sax M. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature. 1992 Oct 29;359(6398):801–806. doi: 10.1038/359801a0. [DOI] [PubMed] [Google Scholar]
  49. Swaminathan S., Furey W., Pletcher J., Sax M. Residues defining V beta specificity in staphylococcal enterotoxins. Nat Struct Biol. 1995 Aug;2(8):680–686. doi: 10.1038/nsb0895-680. [DOI] [PubMed] [Google Scholar]
  50. Thibodeau J., Cloutier I., Lavoie P. M., Labrecque N., Mourad W., Jardetzky T., Sékaly R. P. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science. 1994 Dec 16;266(5192):1874–1878. doi: 10.1126/science.7997881. [DOI] [PubMed] [Google Scholar]
  51. Tomai M. A., Schlievert P. M., Kotb M. Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immun. 1992 Feb;60(2):701–705. doi: 10.1128/iai.60.2.701-705.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Turner T. N., Smith C. L., Bohach G. A. Residues 20, 22, and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2. Infect Immun. 1992 Feb;60(2):694–697. doi: 10.1128/iai.60.2.694-697.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES